Vertex Pharmaceuticals stock falls after pain drug fails in Phase 2 study
Director G. Kennedy Thompson of Pinnacle Financial Partners Inc (NASDAQ:PNFP) acquired 10,000 shares of the company’s common stock on August 1, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were purchased at a price of $85.65, totaling $856,500. The timing of this purchase is notable as InvestingPro data shows the stock has declined nearly 30% over the past six months, with technical indicators suggesting oversold conditions.
Following the transaction, Thompson directly owns 28,372 shares of Pinnacle Financial Partners. Additionally, Thompson indirectly owns 2,000 shares of PNFP common stock and 20,000 depositary shares
In other recent news, Pinnacle Financial Partners reported quarterly earnings that exceeded expectations, driven by higher fees, increased net interest income, and a lower provision, despite higher expenses from increased incentive compensation. Piper Sandler maintained a Neutral rating with a $110.00 price target after these results. Meanwhile, Citi raised its price target on Pinnacle Financial Partners to $140.00, citing strong loan growth and positive hiring trends expected to continue into 2026. In contrast, Stephens downgraded the stock from Overweight to Equal Weight, setting a price target of $133.00 due to concerns over the pending acquisition of Synovus (NYSE:SNV) Financial Corp, which is anticipated to close in the first quarter of 2026. Stephens also lowered its price target to $104.00, reflecting a price-to-earnings methodology aligned with similar institutions. Additionally, Fitch Ratings affirmed Pinnacle’s issuer default ratings but revised the outlook to negative following the acquisition announcement. These developments highlight the mixed analyst perspectives on Pinnacle Financial Partners amid its strategic moves and financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.